The epidemiology, healthcare and societal burden and costs of asthma in the UK and its member nations: analyses of standalone and linked national databases

BMC Medicine

Research Article

Gwyneth A. Davies¹  Aziz Sheikh²  Colin R. Simpson²  Mome Mukherjee³  Andrew Stoddart³  Bright I. Nwaru⁴  Michael D. Shields⁵  Brian McKinstry⁶  Ronan A. Lyons⁷  Amrita Bandyopadhyay⁷  Martin Heaven⁷  Colin Fischbacher⁸  David P. Strachan⁹  Ramyani P. Gupta⁹  Christopher Dibben^1,10  Deborah Fitzsimmons^1,11  Angela Farr^1,11  Ceri J. Phillips^1,11  Chantelle Aftab^1,12 

[1] Asthma & Allergy Group, Institute of Life Science, Swansea University Medical School, Swansea University, Singleton Park, SA2 8PP, Swansea, UK;Asthma UK Centre for Applied Research, Centre for Medical Informatics, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, EH8 9AG, Edinburgh, UK;Asthma UK Centre for Applied Research, Centre for Medical Informatics, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, EH8 9AG, Edinburgh, UK;Edinburgh Clinical Trials Unit, Centre for Medical Informatics, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, EH8 9AG, Edinburgh, UK;Asthma UK Centre for Applied Research, Centre for Medical Informatics, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, EH8 9AG, Edinburgh, UK;School of Health Sciences, University of Tampere, 33014, Tampere, Finland;Centre for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Wellcome Wolfson Institute Experimental Medicine, Queen’s University Belfast, 97 Lisburn Road, BT9 7BL, Belfast, UK;Edinburgh Clinical Trials Unit, Centre for Medical Informatics, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, EH8 9AG, Edinburgh, UK;Farr Institute, Swansea University Medical School, Singleton Park, SA2 8PP, Swansea, UK;Information Services Division (ISD), NHS National Services Scotland, Room 111, Gyle Square, 1 South Gyle Crescent, EH12 9EB, Edinburgh, UK;Population Health Research Institute, St George’s, University of London, Cranmer Terrace, SW17 0RE, London, UK;School of Geosciences, The University of Edinburgh, EH8 9AG, Edinburgh, UK;Swansea Centre for Health Economics (SCHE), College of Human and Health Science, Swansea University, Singleton Park, SA2 8PP, Swansea, UK;The University of Edinburgh & The Royal College of Surgeons of Edinburgh, Clinical Surgery, Royal Infirmary of Edinburgh, EH16 4SA, Edinburgh, UK;

关键词: Asthma;    Epidemiology;    Burden;    Cost;    UK;   

DOI  :  10.1186/s12916-016-0657-8

 received in 2016-03-16, accepted in 2016-07-15,  发布年份 2016

来源: Springer

【 摘 要 】

BackgroundThere are a lack of reliable data on the epidemiology and associated burden and costs of asthma. We sought to provide the first UK-wide estimates of the epidemiology, healthcare utilisation and costs of asthma.MethodsWe obtained and analysed asthma-relevant data from 27 datasets: these comprised national health surveys for 2010–11, and routine administrative, health and social care datasets for 2011–12; 2011–12 costs were estimated in pounds sterling using economic modelling.ResultsThe prevalence of asthma depended on the definition and data source used. The UK lifetime prevalence of patient-reported symptoms suggestive of asthma was 29.5 % (95 % CI, 27.7–31.3; n = 18.5 million (m) people) and 15.6 % (14.3–16.9, n = 9.8 m) for patient-reported clinician-diagnosed asthma. The annual prevalence of patient-reported clinician-diagnosed-and-treated asthma was 9.6 % (8.9–10.3, n = 6.0 m) and of clinician-reported, diagnosed-and-treated asthma 5.7 % (5.7–5.7; n = 3.6 m). Asthma resulted in at least 6.3 m primary care consultations, 93,000 hospital in-patient episodes, 1800 intensive-care unit episodes and 36,800 disability living allowance claims. The costs of asthma were estimated at least £1.1 billion: 74 % of these costs were for provision of primary care services (60 % prescribing, 14 % consultations), 13 % for disability claims, and 12 % for hospital care. There were 1160 asthma deaths.ConclusionsAsthma is very common and is responsible for considerable morbidity, healthcare utilisation and financial costs to the UK public sector. Greater policy focus on primary care provision is needed to reduce the risk of asthma exacerbations, hospitalisations and deaths, and reduce costs.

【 授权许可】

CC BY   
© The Author(s). 2016